75
Participants
Start Date
May 22, 2025
Primary Completion Date
November 3, 2026
Study Completion Date
June 20, 2027
Teclistamab
Teclistamab will be administered subcutaneously.
RECRUITING
All India Institute of Medical Sciences, New Delhi
RECRUITING
Rajiv Gandhi Cancer Institute & Research Centre, New Delhi
RECRUITING
Post Graduate Institute of Medical Education And Research PGIMER, Chandigarh
RECRUITING
Bhagwan Mahaveer Cancer Hospital & Research Centre, Jaipur
RECRUITING
Tata Memorial Hospital, Mumbai
RECRUITING
KIMS-Kingsway Hospitals, Nagpur
RECRUITING
M S Ramaiah Medical College and Hospital, Bangalore
RECRUITING
Tata Medical Center, Kolkata
Lead Sponsor
Johnson & Johnson Private Limited
INDUSTRY